European Biomarker Analysis Market


USD 4,950.00

* Required Fields

USD 4,950.00


Be the first to review this product

This research service gives a detailed analysis of the biomarker analysis market in Europe from 2005-2015.

Table of Contents

European Biomarker Analysis Market, Executive SummaryOverview of the European Biomarker Analysis MarketExecutive Summary of the European Biomarker Analysis MarketEuropean Biomarker Analysis Market, Exchange Rates and Glossary of TermsGlossary of Terms and Exchange RatesDefinitionsExchange RatesEuropean Biomarker Analysis Market, Industry ChallengesChallenges Faced by the European Biomarker Analysis IndustryIndustry Challenges for the European Biomarker Analysis MarketEuropean Biomarker Analysis Market, Total European Biomarker Analysis MarketTotal Biomarker Analysis Market - EuropeMulti-parametric Analysis of Companies in the Biomarkers SpaceIntroductionMarket OverviewScope of the ResearchResearch MethodologyMarket Engineering MeasurementsStakeholder ImplicationsMarket DriversMarket RestraintRevenue ForecastsCompetitive StructureGlobal Biomarker Initiatives: Present and Future DirectionsAnalysis of Biomarker Thrust Areas by DiseaseKey Alliances in the Biomarker SpaceCompetitive Analysis of Biomarker CompaniesAnalysis of Opportunities and Market Attractiveness by SegmentBioinformatics Companies in the Biomarkers MarketAssessment of the Theranostics AmbitAnalysis of Market Opportunities for CROs in the Biomarkers MarketAnalysis of Market Attractiveness by Geographical RegionEuropean Biomarker Analysis Market, Market Engineering Strategic RecommendationsStrategic RecommendationsStrategic Recommendations for the European Biomarker Analysis MarketEuropean Biomarker Analysis Market, Database of Key Industry ParticipantsKey Industry ParticipantsList of Key Industry ParticipantsEuropean Biomarker Analysis Market, Decision Support DatabaseDecision Support Databases for the European Biomarker Analysis MarketGovernment Healthcare ExpenditurePharmaceutical R&D ExpenditurePer cent Pharmaceutical R&D ExpenditureGovernment Biotechnology R&D ExpenditurePrivate Healthcare Expenditure

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.